These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 24488421)

  • 21. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-cyclic citrullinated peptide antibodies in adult patients with juvenile idiopathic arthritis.
    Skare TS; Nisihara RM; Silva RM; Munhoz da Silva DJ; Gameiro Silva MB; Utiyama SR
    J Clin Rheumatol; 2011 Dec; 17(8):421-3. PubMed ID: 22089992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of revised International League of Associations for Rheumatology classification criteria for juvenile idiopathic arthritis in Spanish children (Edmonton 2001).
    Merino R; de Inocencio J; García-Consuegra J
    J Rheumatol; 2005 Mar; 32(3):559-61. PubMed ID: 15742453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overlap of International League of Associations for Rheumatology and Preliminary Pediatric Rheumatology International Trials Organization Classification Criteria for Nonsystemic Juvenile Idiopathic Arthritis in an Established UK Multicentre Inception Cohort.
    Shoop-Worrall SJW; Macintyre VG; Ciurtin C; Cleary G; McErlane F; Wedderburn LR; ; Hyrich KL
    Arthritis Care Res (Hoboken); 2024 Jun; 76(6):831-840. PubMed ID: 38212149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy.
    de Man YA; Bakker-Jonges LE; Goorbergh CM; Tillemans SP; Hooijkaas H; Hazes JM; Dolhain RJ
    Ann Rheum Dis; 2010 Feb; 69(2):420-3. PubMed ID: 19282308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus.
    Popescu C; Zofotă S; Bojincă V; Ionescu R
    Rom J Intern Med; 2013; 51(3-4):179-87. PubMed ID: 24620631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.
    Jansen AL; van der Horst-Bruinsma I; van Schaardenburg D; van de Stadt RJ; de Koning MH; Dijkmans BA
    J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D; Gülmez D; Hasçelik G
    Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibodies to mutated citrullinated vimentin and some associated autoantibodies in juvenile idiopathic arthritis].
    Zhang L; Ru J; Jie X; Che G; Jin X; Li X
    Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):948-51. PubMed ID: 26887552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
    Maraina CH; Nurdayana AK; Rusni D; Azwany Y
    Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic utility of anti-citrullinated protein antibody and its comparison with rheumatoid factor in rheumatoid arthritis.
    Khan AH; Jafri L; Hussain MA; Ishaq S
    J Coll Physicians Surg Pak; 2012 Nov; 22(11):711-5. PubMed ID: 23146852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
    Uçar F; Çapkin E; Karkucak M; Yücel B; Sönmez M; Alver A; Kaklikkaya N; Tosun M; Alemdaroğlu E; Solak M
    Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of rheumatoid factor isotypes and anti-cyclic citrullinated peptides in Malaysian rheumatoid arthritis patients.
    Gomez EL; Gun SC; Somnath SD; D'Souza B; Lim AL; Chinna K; Radhakrishnan AK
    Int J Rheum Dis; 2011 Feb; 14(1):12-7. PubMed ID: 21303477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA).
    Berntson L; Nordal E; Fasth A; Aalto K; Herlin T; Nielsen S; Rygg M; Zak M; Rönnelid J;
    Pediatr Rheumatol Online J; 2014; 12():22. PubMed ID: 24944545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis.
    Ferucci ED; Majka DS; Parrish LA; Moroldo MB; Ryan M; Passo M; Thompson SD; Deane KD; Rewers M; Arend WP; Glass DN; Norris JM; Holers VM
    Arthritis Rheum; 2005 Jan; 52(1):239-46. PubMed ID: 15641089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and significance of serum 14-3-3η in juvenile idiopathic arthritis.
    Reyhan I; Zhukov OS; Lagier RJ; Bridgforth RF; Williams GJ; Popov JM; Naides SJ; Reiff A
    Pediatr Rheumatol Online J; 2021 Feb; 19(1):14. PubMed ID: 33593401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.
    Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J
    N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.